STOCK TITAN

Axcelis Announces Successful Purion XEmax Eval Closure at Leading Semiconductor Foundry

(Moderate)
(Very Positive)
Tags

Axcelis (Nasdaq: ACLS) announced the successful evaluation closure of its Purion XEmax high energy implanter at a leading semiconductor foundry on July 28, 2026. The qualified system will be used in production of Power Management Integrated Circuits (PMICs), an emerging application requiring advanced 15 MeV implant capability.

According to Axcelis, Purion XEmax features a dual LINAC design with patented Boost Technology, enabling the industry's highest implant energies up to 15 MeV and metals reduction for next generation devices. It is part of the Purion XE Series, which offers a range of high energy ion implanters tailored for different power and high-volume applications.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ACLS

-6.31%
34 alerts
-6.31% Session close to close
-10.2% Trough in 32 hr 21 min
$3.95B Market Cap
0.8x Rel. Volume

In the Jul 28 session, ACLS declined 6.31%, reflecting a notable negative market reaction. Argus tracked a trough of -10.2% from its starting point during tracking. Our momentum scanner triggered 34 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

System qualified for emerging PMIC device application requiring advanced 15 MeV implant capability

BEVERLY, Mass., July 28, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the successful Purion XEmax high energy implanter evaluation closure at a leading foundry. The system will be used for the production of Power Management Integrated Circuits (PMIC).

Axcelis’ Purion XEmax™ high energy implanter provides the industry’s highest beam currents over the broadest energy range — up to 15MeV.

President and CEO Russell Low commented, "We're excited to be a part of this important, emerging market and the opportunity to provide the most advanced high energy ion implant technology to chipmakers to support their next generation device development. The successful evaluation closure highlights growing customer requirements for even higher energy implant recipes on advanced PMIC devices, which only the Purion XEmax provides. The system features a dual LINAC design with patented Boost Technology for the industry's highest energies up to 15 MeV."

Power Management Integrated Circuits (PMICs) are highly specialized semiconductors that function as the central nervous system for power in modern electronics. They consolidate multiple power control functions—such as voltage regulation, battery charging, and thermal management—into a single chip, driving efficiency and optimizing battery life in everything from smartphones to electric vehicles.

The Purion XE Series:
Our Purion XE Series of ion implanters have rapidly earned a reputation as the industry standard for today's demanding high energy recipes. Their unique RF Linear Accelerator (LINAC) technology offers higher reliability, a wider energy range and greater productivity than competing platforms, with superior metals contamination control. The Purion High Energy Series includes a variety of implanters allowing customers to select the optimal energy level for their application: the industry leading Purion XE; the Purion EXE for enhanced productivity; the Purion VXE for high volume and higher energy applications; the Purion XE Power Series for power devices; and, the Purion XEmax with patented Boost™ technology for metals reduction and the ultra-high energies required for next generation devices.

About Axcelis
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:

Investor Relations Contact:
David Ryzhik
Senior Vice President and Interim CFO
Telephone: (978) 787-2352
Email: David.Ryzhik@axcelis.com

Press/Media Relations Contact:
Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: Maureen.Hart@axcelis.com

Safe Harbor Statement
Statements made in this press release that are not of known historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. These statements, which include statements regarding our products, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, including the risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the risk factors described in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the information or statements made in this press release.

Axcelis

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-successful-purion-xemax-eval-closure-at-leading-semiconductor-foundry-302836030.html

SOURCE Axcelis Technologies, Inc.

FAQ

What did Axcelis (NASDAQ: ACLS) announce about the Purion XEmax on July 28, 2026?

Axcelis announced the successful evaluation closure of its Purion XEmax high energy implanter at a leading semiconductor foundry. According to Axcelis, the qualified system will now be used for production of Power Management Integrated Circuits (PMICs) in an emerging, advanced high energy implant application.

How will the Purion XEmax system be used in PMIC production for Axcelis (ACLS)?

The Purion XEmax will be used for production of Power Management Integrated Circuits at a leading foundry. According to Axcelis, these PMIC applications require advanced 15 MeV implant capability and ultra-high energies that the Purion XEmax provides through its dual LINAC design and Boost Technology.

What high energy implant capabilities does Axcelis Purion XEmax offer for PMIC devices?

Purion XEmax offers implant energies up to 15 MeV for advanced PMIC devices. According to Axcelis, the system’s dual LINAC architecture with patented Boost Technology delivers ultra-high energies and metals reduction, addressing growing customer requirements for higher energy implant recipes on next generation power management chips.

What is the Axcelis Purion XE Series and how does it support high energy ion implantation?

The Purion XE Series is Axcelis’s family of high energy ion implanters for demanding recipes. According to Axcelis, it uses RF LINAC technology to provide higher reliability, wider energy range, greater productivity, and superior metals contamination control across models like Purion XE, EXE, VXE, XE Power, and XEmax.

Why are Power Management Integrated Circuits (PMICs) important in modern electronics?

PMICs act as the central nervous system for power in modern electronics by consolidating multiple power control functions into one chip. According to Axcelis, they manage voltage regulation, battery charging, and thermal control, improving efficiency and battery life in products from smartphones to electric vehicles.

What technologies enable the 15 MeV performance of Axcelis’s Purion XEmax implanter?

Purion XEmax achieves up to 15 MeV implant energies using a dual LINAC design and Boost Technology. According to Axcelis, this patented Boost Technology supports ultra-high energies and metals reduction, making the system suitable for next generation devices requiring very high energy ion implantation.